- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 125,740 | 24.07.24 20:17:29 | +1,360 | +1,09% | 125,730 | 125,750 | 124,990 | 124,380 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 103,920 | 24.07.24 20:17:04 | +1,550 | +1,51% | 103,720 | 104,080 | 102,000 | 102,370 |
